D-0650-2017 Class III Terminated
FDA drug recall D-0650-2017 was initiated by Lupin Pharmaceuticals Inc. on Dec 7, 2015 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications; Impurity A The recall status is terminated (terminated Apr 10, 2017). Affected quantity: 15,168 bottes.
Recall Details
- Product Type
- Drugs
- Report Date
- Apr 12, 2017
- Initiation Date
- Dec 7, 2015
- Termination Date
- Apr 10, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 15,168 bottes
Product Description
Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09
Reason for Recall
Failed Impurities/Degradation Specifications; Impurity A
Distribution Pattern
Nationwide
Code Information
Batch number G303703, exp 3/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0650-2017
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026